drugset / Trial / NCT00362531

Tacrolimus Combined With Prednisone Treatment of Idiopathic Membranous Nephropathy and Nephrotic Syndrome

NCT00362531

Phase 2/3 Completed Peking University
RandomizedParallel-groupOpen-labelTreatment

Summary

Idiopathic membranous nephropathy (IMN) is one of the most common forms of nephrotic syndrome (NS) in adults and is usually treated by corticosteroids in combination with cytotoxic drugs especially cyclophosphamide or cyclosporine. Tacrolimus, a new immunosuppressive agent, was proved to be effective in treating refractory NS. Whether it is effective in IMN has not been reported. We therefore undertook a multi-center, controlled study to investigate the efficacy and safety profile of tacrolimus compared with cyclophosphamide in the treatment of patients with idiopathic membranous nephropathy and nephrotic syndrome.

Timeline

Start
2004-11
Primary completion
Completion
2007-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Tacrolimus Small molecule
Background Prednisone Other / unclassified